Graham Mills

Principal at Abingworth LLP

Speaker

Graham joined Abingworth’s London office in 2022 working with the transatlantic team in evaluating new investment opportunities and supporting existing portfolio companies in a therapeutic area-agnostic approach. He is actively involved with a number of portfolio companies including Iambic Therapeutics and AdvanCell.

Previously, Graham was Founder & Managing Director at healthcare-focused tech startup Techspert, a venture-backed enterprise he built across three continents to better enable healthcare data access. Before & alongside this, Graham worked actively in the investment teams of JJDC and Seroba Life Sciences, developing broad investment theses through new opportunity evaluation and detailed therapeutic landscape analyses.

Graham holds a PhD in Medical Biology from the University of Cambridge, and a BA in Genetics from Trinity College Dublin.